Literature DB >> 28228710

HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature.

Arpine Gevorgyan1, Giacomo Bregni2, Giulia Galli1, Elisa Zanardi2, Filippo de Braud1, Serena Di Cosimo1.   

Abstract

BACKGROUND: Neuroendocrine carcinoma is an uncommon histology for breast cancer. CASE REPORT: Our patient underwent right quadrantectomy for a neuroendocrine carcinoma in 1984 and had a bone relapse 30 years later. After thorough pathological and immunohistochemical analysis the diagnosis was confirmed and HER2 amplification was observed. Here we discuss the management, rationale and results of HER2-targeted therapy in advanced neuroendocrine breast carcinoma.

Entities:  

Keywords:  Breast carcinoma; Neuroendocrine carcinoma; Trastuzumab

Year:  2016        PMID： 28228710      PMCID： PMC5290429          DOI： 10.1159/000453572

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


  6 in total

Review 1.  Expression of the neuroendocrine phenotype in carcinomas of the breast.

Authors:  A Sapino; L Righi; P Cassoni; M Papotti; F Pietribiasi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

Review 2.  Primary neuroendocrine breast cancer, how much do we know so far?

Authors:  Homam Alkaied; Kassem Harris; Basem Azab; Qun Dai
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

3.  'Carcinoid' tumours of the breast: the morphological spectrum of argyrophil carcinomas.

Authors:  J G Azzopardi; P Muretto; P Goddeeris; V Eusebi; J M Lauweryns
Journal:  Histopathology       Date:  1982-09       Impact factor: 5.087

4.  Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast.

Authors:  G Bussolati; P Gugliotta; A Sapino; V Eusebi; R V Lloyd
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

5.  Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.

Authors:  Fernando A Angarita; Jorge L Rodríguez; Eugenio Meek; Jesus O Sánchez; Mauricio Tawil; Lilian Torregrosa
Journal:  World J Surg Oncol       Date:  2013-06-05       Impact factor: 2.754

6.  Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database.

Authors:  Jun Wang; Bing Wei; Constance T Albarracin; Jianhua Hu; Susan C Abraham; Yun Wu
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430
  6 in total
  6 in total

Review 1.  Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives.

Authors:  Hongna Sun; Shuang Dai; Junnan Xu; Linan Liu; Jiaxing Yu; Tao Sun
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

Review 2.  Neuroendocrine breast carcinoma: a rare but challenging entity.

Authors:  Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

3.  Rare Human Epidermal Growth Factor Receptor 2 (HER-2)-Positive Neuroendocrine Carcinoma of the Breast: A Case Report with 9-Year Follow-up.

Authors:  Inga Marijanović; Marija Kraljević; Teo Buhovac; Dragana Karan Križanac
Journal:  Am J Case Rep       Date:  2020-10-17

Review 4.  Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues.

Authors:  Marco Gallo; Severo Campione; Valentina Di Vito; Nicoletta Fortunati; Fabio Lo Calzo; Erika Messina; Rosaria Maddalena Ruggeri; Antongiulio Faggiano; Annamaria Anita Livia Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

Review 5.  Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.

Authors:  Yukinori Ozaki; Sakiko Miura; Ryosuke Oki; Teppei Morikawa; Keita Uchino
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 6.  Neuroendocrine Cancer of the Breast: A Rare Entity.

Authors:  Azzurra Irelli; Maria Maddalena Sirufo; Luca Morelli; Carlo D'Ugo; Lia Ginaldi; Massimo De Martinis
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.